Analysis of T-cell repertoire in hepatitis-associated aplastic anemia

Blood

Volumn 103, Issue 12, 2004, Pages 4588-4593

  Lu, Jun ^a   Basu, Atanu ^a   Melenhorst, J Joseph ^a   Young, Neal S ^a   Brown, Kevin E ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CELL TYPE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEPATITIS; HEPATITIS ASSOCIATED APLASTIC ANEMIA; HUMAN; HUMAN CELL; IMMUNE MEDIATED INJURY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER HISTOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SPECTRATYPING; SYNDROME DELINEATION; T LYMPHOCYTE ACTIVATION; VIRUS HEPATITIS;

EID: 2942535837     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-11-3959     Document Type: Article

References (44)

1. Baumelou E, Guiguet M, Mary JY. Epidemiology of aplastic anemia in France: a case-control study, I: medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood. 1993;81:1471-1478.
2. Tzakis AG, Arditi M, Whitington PF, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med. 1988;319:393-396.
3. Itterbeek P, Vandenberghe P, Nevens F, et al. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Transpl Int. 2002;15:117-123.
4. Hagler L, Pastore RA, Bergin JJ, Wrensch MR. Aplastic anemia following viral hepatitis: report of two fatal cases and literature review. Medicine (Baltimore). 1975;54:139-164.
5. Hibbs JR, Frickhofen N, Rosenfeld SJ, et al. Aplastic anemia and viral hepatitis: non-A, non-B, non-C? JAMA. 1992;267:2051-2054.
6. Brown KE, Wong S, Young NS. Prevalence of GBV-C/HGV, a novel 'hepatitis' virus, in patients with aplastic anemia. Br J Haematol. 1997;97:492-496.
7. Safadi R, Or R, Ilan Y, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant. 2001;27:183-190.
8. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med. 1997;336:1059-1064.
9. Foon KA, Mitsuyasu RT, Schroff RW, et al. Immunologic defects in young male patients with hepatitis-associated aplastic anemia. Ann Intern Med. 1984;100:657-662.
10. Kojima S, Matsuyama K, Kodera Y, Okada J. Circulating activated suppressor T lymphocytes in hepatitis-associated aplastic anaemia. Br J Haematol. 1989;71:147-151.
11. Kiem HP, McDonald GB, Myerson D, et al. Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors. Biol Blood Marrow Transplant. 1996;2:93-99.
12. Yang PM, Su IJ, Lai MY, et al. Immunohistochemical studies on intrahepatic lymphocyte infiltrates in chronic type B hepatitis, with special emphasis on the activation status of the lymphocytes. Am J Gastroenterol. 1988;83:948-953.
13. Montano L, Aranguibel F, Boffill M, et al. An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease. Hepatology. 1983;3:292-296.
14. Pham BN, Mosnier JF, Walker F, et al. Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B. Clin Exp Immunol. 1994;97:403-410.
15. van Hattum J, van Oudenaren A, Schalm SW, Visser JW, Benner R. T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infection. Scand J Gastroenterol. 1984;19:497-501.
16. Pham BN, Degos F, Mosnier JF, et al. Restriction of V beta gene usage of liver-derived lymphocytes in chronic hepatitis B and C. Hum Immunol. 1996;49:56-63.
17. Umemura T, Yoshizawa K, Ota M, et al. Analysis of T cell repertoire in the liver of patients with chronic hepatitis C. Clin Exp Immunol. 2000;121:120-126.
18. Yoshizawa K, Ota M, Katsuyama Y, et al. T cell repertoire in the liver of patients with autoimmune hepatitis. Hum Immunol. 1999;60:806-815.
19. Gorski J, Yassai M, Zhu X, et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: correlation with immune status. J Immunol. 1994;152:5109-5119.
20. Even J, Lim A, Puisieux I, et al. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol. 1995;146:65-80.
21. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today. 1995;16:176-181.
22. Pannetier C, Cochet M, Darche S, et al. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A. 1993;90:4319-4323.
23. Inada H, Yoshizawa K, Ota M, et al. T cell repertoire in the liver of patients with primary biliary cirrhosis. Hum Immunol. 2000;61:675-683.
24. Wu CJ, Chillemi A, Alyea EP, et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood. 2000;95:352-359.
25. Sing GK, Li D, Chen X, et al. A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology. 2001;33:1288-1298.
26. Lohr HF, Pingel S, Weyer S, Fritz T, Galle PR. Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis. Scand J Immunol. 2003;57:384-390.
27. Safadi R, Or R, Ilan Y, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant. 2001;27:183-190.
28. Tsai SL, Chen YM, Chen MH, et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology. 1998;115:954-965.
29. Lehner PJ, Wang EC, Moss PA, et al. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med. 1995;181:79-91.
30. Lohse AW, Dienes HP, Meyer zum Buschenfelde KH. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology. 1998;27:1536-1543.
31. Manz CY, Dietrich PY, Schnuriger V, Nissen C, Wodnar-Filipowicz A. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia. Blood Cells Mol Dis. 1997;23:110-122.
32. Zeng W, Nakao S, Takamatsu H, et al. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia. Blood. 1999;93:3008-3016.
33. Kook H, Risitano AM, Zeng W, et al. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. Blood. 2002;99:3668-3675.
34. Karadimitris A, Manavalan JS, Thaler HT, et al. Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood. 2000;96:2613-2620.
35. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 1997;336:1365-1372.
36. Risitano AM, Kook H, Zeng W, et al. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood. 2002;100:178-183.
37. Zeng W, Maciejewski JP, Chen G, Young NS. Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest. 2001;108:765-773.
38. Allegretta M, Albertini RJ, Howell MD, et al. Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. J Clin Invest. 1994;94:105-109.
39. Musette P, Bequet D, Delarbre C, et al. Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients. Proc Natl Acad Sci U S A. 1996;93:12461-12466.
40. Goronzy JJ, Bartz-Bazzanella P, Hu W, et al. Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest. 1994;94:2068-2076.
41. Li Y, Sun GR, Tumang JR, Crow MK, Friedman SM. CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells: evidence for an antigen-driven response. J Clin Invest. 1994;94:2525-2531.
42. Tanaka A, Iwabuchi S, Takatori M, et al. Clonotypic analysis of T cells in patients with autoimmune and viral hepatitis. Hepatology. 1997;25:1070-1076.
43. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 1993;362:68-70.
44. Mantegazza R, Andreetta F, Bernasconi P, et al. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis: restricted V alpha/beta rearrangements may indicate antigen-driven selection. J Clin Invest. 1993;91:2880-2886.